Skip to Main Content

Radiation Oncology Program

The UCSF Radiation Oncology Program is among the nation's best for patients who require radiation therapy. We match you with a team of experts on your particular cancer and the best techniques for treating it. Along with UCSF's advanced technologies and our safe care practices, this expertise enables us to provide patients with the best possible outcomes.

We specialize in using high-dose, precisely targeted X-rays to shrink or eliminate tumor cells with minimal damage to surrounding healthy tissues. Depending on the patient, the goal is to destroy cancer, keep it from spreading, or improve quality of life by relieving pain and other symptoms.

Alongside our commitment to outstanding patient care, our team is dedicated to finding safer and more effective cancer therapies through research. Interested patients may have the opportunity to receive promising experimental treatments by joining a clinical trial.

For information on what to expect during your first appointment, how to prepare for your visits and more, please see our FAQ.

Learn more about clinical trials and how they work.

Doctor referral required

Our locations (5)

    Our team

    View providers by category
    • Mission Bay (20)
    • Mount Zion (14)
    • Parnassus (13)
    • UCSF-John Muir Health Cancer Center (4)
    • UCSF – Washington Cancer Center (3)

    Mission Bay (20)

    Decorative Caduceus

    Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Meta...

    Analysis for this endpoint will consist of testing the cause-specific hazard ratio in a Cox proportional hazards model.

    Recruiting

    Decorative Caduceus

    Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

    PFS is defined as the proportion of participants alive without progression of disease from the first day of radiotherapy to progression or death by any cause, whichever occurs first, assessed up to 2 years after the last day of ra...

    Recruiting

    Decorative Caduceus

    Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meni...

    Percentage of patients who are progression-free at the landmark of 12 months from start of treatment based on the target lesion(s) that are receiving radiation treatment will be reported. Tumor progression will be assessed using I...

    Recruiting

    Decorative Caduceus

    A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recur...

    Recruiting

    Decorative Caduceus

    Wearable Activity Tracking to Curb Hospitalizations

    The AUC-ROC of the step count model will measure the performance of a classification model by plotting the rate of true positives against false positives, and the score ranges from 0 - 1. The higher the AUC, the better the model's...

    Recruiting

    Decorative Caduceus

    Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

    Proportion of patients who achieve as their best overall response according to Response Evaluation Criteria in Solid Tumors (RECIST) v. 1.1 criteria: Stable disease (SD), partial response (PR), confirmed Complete Response (CR), or...

    Recruiting

    Decorative Caduceus

    Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

    Association between phenotypic characteristics and initial levels and trajectories of CRF severity will be assessed using a hierarchical linear model (HLM) approach.

    Recruiting

    Decorative Caduceus

    Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

    Dose-limiting toxicities (DLTs) are defined in Section 5.2.3. DLT determination will assess adverse events (AEs) graded according to CTCAE v5.0, including findings on physical exam, vital signs, laboratory testing, and spontaneous...

    Recruiting

    Decorative Caduceus

    Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Can...

    Defined per Response Evaluation Criteria in Solid Tumors 1.1, excluding radiation therapy-treated lesions. assessed from initiation of study treatment until discontinuation of treatment. Proportion of response and corresponding ex...

    Recruiting

    Decorative Caduceus

    Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiatio...

    The Taste Assessment is a two-item questionnaire used to determine the overall experiences of the participant taste sensation in the past 7 days; with one item asking about taste alteration and another asking about the interferenc...

    Recruiting

    U.S. News rankings

    • U S  News and World Report badge recognizing UCSF as part of its 2024-2025 Honor Roll

      Among the top hospitals in the nation

    • Best in Northern California and No. 7 in the nation for cancer care

    Accreditations & memberships

    • National Cancer Institute

      The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.

    • Commission on Cancer

      UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.

    • National Comprehensive Cancer Network

      UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.

    Recommended reading

    Support services

    Preparing for your appointment

    What to Bring

    • Medical records (must be received two weeks prior to appointment)
    • List of current medications, dosages and prescribing doctors
    • List of any other doctors involved in your care

    Related clinics

    Our research initiatives

    • UCSF-Helen-Diller-Family-Comprehensive-Cancer-Center-Research-2x

      UCSF Helen Diller Family Comprehensive Cancer Center Research

      UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.

    Can't find what you're looking for?

    UCSF Help Center

    (888) 689-8273

    Share